{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:34:37Z","timestamp":1793208877272,"version":"4.5.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:p>\n                    Ovarian dysfunction is a life-altering late effect in female childhood cancer survivors (CCS), yet early identification of ovarian injury remains challenging. This study aimed to evaluate the burden and determinants of ovarian dysfunction in CCS, with a specific focus on treatment-related amenorrhea (TRA) persisting for \u22654 months. Demographic, clinical, and treatment exposure data were obtained from the hospital medical records. Menstrual and hormonal information was collected using a structured proforma. In this single-center cross-sectional study, 186 female CCS (mean age: 21\u00b15\u00a0y) were evaluated after a mean follow-up of 10\u00b15.6 years. Gonadotoxic exposures included chemotherapy (100%) with a mean cumulative cyclophosphamide equivalent dose (CED) of 5.1\u00a0g\/m\n                    <jats:sup>2<\/jats:sup>\n                    , pelvic or craniospinal radiotherapy (6.45%), and hematopoietic stem cell transplantation (4.8%). Hypergonadotropic TRA was observed in 24% (45\/186) of survivors, and 20% (9\/45) of them progressed to acute ovarian failure (AOF). On multivariable analysis, independent predictors of TRA included postpubertal status at diagnosis (OR: 20.45; CI: 4-101.5), solid tumor diagnosis (OR: 5.98; CI: 1.7-8), and CED of \u22657.5\u00a0g\/m\n                    <jats:sup>2<\/jats:sup>\n                    (OR: 4.56; CI: 1.4-14). Prevalence of AOF aligned with established risk categories. As an easily identifiable clinical feature, TRA may help identify survivors suitable for fertility preservation counselling and surveillance for premature ovarian failure.\n                  <\/jats:p>","DOI":"10.1097\/mph.0000000000003282","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:00:09Z","timestamp":1790013609000},"page":"e367-e371","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Ovarian Dysfunction After Gonadotoxic Therapy in Childhood Cancer Survivors: A Cross-Sectional Study From a Resource-Limited Setting"],"prefix":"10.1097","volume":"48","author":[{"given":"Heena","family":"Gajiwala","sequence":"first","affiliation":[{"name":"Department of Pediatric Hematology-Oncology and BMT, Rajiv Gandhi Cancer Institute and Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauri","family":"Kapoor","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology-Oncology and BMT, Rajiv Gandhi Cancer Institute and Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology-Oncology and BMT, Rajiv Gandhi Cancer Institute and Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payal","family":"Malhotra","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology-Oncology and BMT, Rajiv Gandhi Cancer Institute and Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology-Oncology and BMT, Rajiv Gandhi Cancer Institute and Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Arora","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology-Oncology and BMT, Rajiv Gandhi Cancer Institute and Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3482-0774","authenticated-orcid":false,"given":"Anurag","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Statistics, Ram Lal Anand College, University of Delhi, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"R1-20261028","first-page":"17","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20261028","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMsa060185","article-title":"Chronic health conditions in adult survivors of childhood cancer","volume":"355","author":"Oeffinger","year":"2006","journal-title":"N Engl J Med"},{"key":"R3-20261028","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1200\/JCO.2008.20.1541","article-title":"Fertility of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study","volume":"27","author":"Green","year":"2009","journal-title":"J Clin Oncol"},{"key":"R4-20261028","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1210\/jc.2016-3723","article-title":"Premature ovarian insufficiency in childhood cancer survivors: a report from the St. Jude Lifetime Cohort","volume":"102","author":"Chemaitilly","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"R5-20261028","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1200\/JCO.2015.64.3288","article-title":"Recommendations for premature ovarian insufficiency surveillance in female childhood cancer survivors","volume":"34","author":"van Dorp","year":"2016","journal-title":"J Clin Oncol"},{"key":"R6-20261028","first-page":"e75","article-title":"Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults","volume":"16","author":"Anderson","year":"2015","journal-title":"Lancet Oncol"},{"key":"R7-20261028","first-page":"177","article-title":"Ovarian reserve and reproductive age may be determined from measurement of ovarian volume by transvaginal sonography","volume":"16","author":"Wallace","year":"2010","journal-title":"Hum Reprod Update"},{"key":"R8-20261028","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1210\/jc.2006-0020","article-title":"Acute Ovarian Failure in the Childhood Cancer Survivor Study","volume":"91","author":"Chemaitilly","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R9-20261028","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/jnci\/djj243","article-title":"Premature menopause in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study","volume":"98","author":"Sklar","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R10-20261028","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1001\/jama.2013.6296","article-title":"Clinical ascertainment of health outcomes among adults treated for childhood cancer","volume":"309","author":"Hudson","year":"2013","journal-title":"JAMA"},{"key":"R11-20261028","doi-asserted-by":"crossref","first-page":"100727","DOI":"10.1016\/j.lansea.2026.100727","article-title":"Long term outcomes of the Indian childhood cancer survivorship (C2S) cohort: a multicentre study (2016-2024)","volume":"45","author":"Seth","year":"2026","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"R12-20261028","doi-asserted-by":"crossref","first-page":"e2200044","DOI":"10.1200\/GO.22.00044","article-title":"Long-term outcomes in survivors of childhood cancer: a 30-year experience from India","volume":"8","author":"Prasad","year":"2022","journal-title":"JCO Glob Oncol"},{"key":"R13-20261028","first-page":"5075","article-title":"Metabolic syndrome in childhood cancer survivors: delta BMI as a risk factor in lower-middle-income countries","volume":"30","author":"Agarwal","year":"2022","journal-title":"Support Care Cancer"},{"key":"R14-20261028","first-page":"57","article-title":"Bridging gaps in oncofertility: evaluation of reproductive dysfunction and fertility assessment in pediatric cancer survivors","volume":"34","author":"Sarangarajan","year":"2025","journal-title":"Support Care Cancer"},{"key":"R15-20261028","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1200\/jco.2014.32.15_suppl.10010","article-title":"The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study","volume":"32","author":"Green","year":"2014","journal-title":"J Clin Oncol"},{"key":"R16-20261028","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000504200","article-title":"Guidelines for long-term follow-up after childhood cancer: practical implications for the daily work","volume":"43","author":"Gebauer","year":"2020","journal-title":"Oncol Res Treat"},{"key":"R17-20261028","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/humrep\/dew027","article-title":"ESHRE guideline: management of women with premature ovarian insufficiency","volume":"31","author":"Webber","year":"2016","journal-title":"Hum Reprod"},{"key":"R18-20261028","doi-asserted-by":"crossref","first-page":"hoae065","DOI":"10.1093\/hropen\/hoae065","article-title":"Evidence-based guideline: premature ovarian insufficiency","volume":"2024","year":"2024","journal-title":"Hum Reprod Open"},{"key":"R19-20261028","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S1470-2045(19)30818-6","article-title":"Predicting acute ovarian failure in female survivors of childhood cancer: a cohort study in the Childhood Cancer Survivor Study (CCSS) and the St Jude Lifetime Cohort (SJLIFE)","volume":"21","author":"Clark","year":"2020","journal-title":"Lancet Oncol"},{"key":"R20-20261028","first-page":"e369","article-title":"Reproductive function and outcomes in female survivors of childhood cancer","volume":"19","author":"van Dorp","year":"2018","journal-title":"Lancet Oncol"},{"key":"R21-20261028","doi-asserted-by":"crossref","first-page":"R141","DOI":"10.1677\/ERC-10-0002","article-title":"Endocrine complications in long-term survivors of childhood cancers","volume":"17","author":"Chemaitilly","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"R22-20261028","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/humupd\/7.6.535","article-title":"Nugent D. The effects of radiotherapy and chemotherapy on female reproduction","volume":"7","author":"Meirow","year":"2001","journal-title":"Hum Reprod Update"},{"key":"R23-20261028","first-page":"243","article-title":"Gonadal damage from chemotherapy and radiotherapy","volume":"26","author":"Howell","year":"2005","journal-title":"Endocr Rev"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003282","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:00:13Z","timestamp":1793206813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003282","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"assertion":[{"value":"2026-05-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}